8V62 image
Entry Detail
PDB ID:
8V62
EMDB ID:
Title:
Structure of the Human Respirovirus 3 Fusion Protein Bound to Camelid Nanobodies 1D10 and 4C06
Biological Source:
Host Organism:
PDB Version:
Deposition Date:
2023-12-01
Release Date:
2024-05-22
Method Details:
Experimental Method:
Resolution:
3.40 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Fusion glycoprotein F0
Chain IDs:A, B, C
Chain Length:516
Number of Molecules:3
Biological Source:Human respirovirus 3
Polymer Type:polypeptide(L)
Description:Camelid nanobody 1D10
Chain IDs:D, E, F
Chain Length:115
Number of Molecules:3
Biological Source:Lama glama
Polymer Type:polypeptide(L)
Description:Camelid nanobody 4C06
Chain IDs:G, H, I
Chain Length:117
Number of Molecules:3
Biological Source:Lama glama
Ligand Molecules
Primary Citation
Structural basis for potent neutralization of human respirovirus type 3 by protective single-domain camelid antibodies.
Nat Commun 15 5458 5458 (2024)
PMID: 38937429 DOI: 10.1038/s41467-024-49757-1

Abstact

Respirovirus 3 is a leading cause of severe acute respiratory infections in vulnerable human populations. Entry into host cells is facilitated by the attachment glycoprotein and the fusion glycoprotein (F). Because of its crucial role, F represents an attractive therapeutic target. Here, we identify 13 F-directed heavy-chain-only antibody fragments that neutralize recombinant respirovirus 3. High-resolution cryo-EM structures of antibody fragments bound to the prefusion conformation of F reveal three distinct, previously uncharacterized epitopes. All three antibody fragments bind quaternary epitopes on F, suggesting mechanisms for neutralization that may include stabilization of the prefusion conformation. Studies in cotton rats demonstrate the prophylactic efficacy of these antibody fragments in reducing viral load in the lungs and nasal passages. These data highlight the potential of heavy-chain-only antibody fragments as effective interventions against respirovirus 3 infection and identify neutralizing epitopes that can be targeted for therapeutic development.

Legend

Protein

Chemical

Disease

Primary Citation of related structures